BridgeMD
New treatment option for Subjective Cognitive Decline (SCD)
Official title Testing the Cog-Fun Aging Program for Older Adults With Subjective Cognitive Decline
ClinicalTrials.gov ID: NCT06816797
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if the Cog-Fun Aging program helps older adults with Subjective Cognitive Decline (SCD) manage memory challenges and improve their daily lives. The main questions it aims to answer are: Does the program help participants better understand their cognitive challenges in daily life?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- experiencing memory changes and feeling concerned about them
- a score of 23 or higher on the MoCA (Montreal Cognitive Assessment)
- ability to speak and understand Hebrew sufficiently to participate in a Hebrew-speaking group
You likely can't join if
- a self-reported health condition that significantly impacts functioning (e.g., uncontrolled diabetes, severe heart/lung disease)
- residing in a medical institution or nursing home
- currently participating in another SCD treatment
The study team makes the final eligibility decision.
Where it's taking place
- Jerusalem, Israel
- Misgav Regional Council, Israel
- Sde Warburg, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jerusalem, Israel; Misgav Regional Council, Israel; Sde Warburg, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.